The in vivo mechanism of action of CTLA4Ig

Journal of Immunology

Volumn 156, Issue 6, 1996, Pages 2294-2299

  Judge, Thomas A ^a   Tang, Aimin ^a   Spain, Lisa M ^a   Gratiot Deans, Jeanne ^b   Sayegh, Mohamed H ^c   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD28 ANTIGEN; CYTOCHROME C; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLONAL ANERGY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; COLUMBIDAE; CYTOCHROME C GROUP; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TH1 CELLS;

EID: 0029871741     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. von Boehmer, H., and P. Kistelow 1990. Self-nonself discrimination by T cells Science 248.1369.
2. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson 1994 The B7 and CD28 receptor families Immunol. Today 15:321.
3. Harding, F. A., J. G. McArthur, J. A. Gross, D H Raulet, and J. P. Allison 1991. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Nature 356:607.
4. Boussiotis, V. A., G. J. Freeman, G Gray, J. Gribben, and L. M. Nadler 1993. B7 but not intracellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med 178:1753.
5. Linsley, P. S., W. Brady, L Grosmaire, A. Aruffo, N K. Damle, and J A. Ledbetter. 1991 Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173:721.
6. Linsley, P. S., P. M. Wallace, J Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbeuer, C. Singh, and M. A Tepper. 1992 Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257 792
7. Lenschow, D. J , Y. Zeng, J R. Thistlewaite, A. Montag, W. Brady, M G. Gibson, P. S Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
8. Turka, L. A., P S. Linsley, H. Lin, W. Brady, J. M Leiden, R.-Q. Wei, M. L. Gibson, X -G. Zheng, S. Myrdal, D. Gordon, T Bailey, S F. Bolling, and C B. Thompson. 1992. T cell activation by the CD28-ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl. Acad. Sci. USA 89.11102.
9. Finck, B K., P. S. Linsley, and D. Wolsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225
10. Wallace, P. M., J. N. Rodgers, G. M Leytze, J. S Johnson, and P. S. Linsley. 1995. Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment. J Immunol. 154:5885
11. Lin, H., S F Bolling, P S. Linsley, R.-Q. Wei, D. Gordon, C. B. Thompson, and L. A Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp Med. 178:1801.
12. Sayegh, M. H , E. Akalin, W. W. Hancock, M. E Russell, C B. Carpenter, P. S. Linsley, and L A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.
13. L. Immunity 3:87.
14. McCormack, J. E., J. Kappler, and P. Marrack. 1994. Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo Proc. Natl. Acad Sci. USA 91:2086.
15. lo thymocytes in vivo. Science 1990. 1720
16. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909.
17. Samuelson, L. E , R N. Germain, and R. H. Schwartz. 1983 Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. Proc Natl Acad. Sci. USA 80:6972.
18. Spain, L M , J. L Jorgenson, M. M. Davis, and L. J Berg 1994. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J. Immunol. 152:1702.
19. Yang, X , and K. Hayglass 1993 A simple, sensitive, dual mAb based ELISA for murine gamma interferon determination: comparison with two common bioassays. J Immunol 14 129.
20. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B R. Hubbard, M. K. Gately, and F. D. Finkelman 1994 Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 152:1047.
21. Cher, D. J., and T. R. Mosmann. 1987. Two types of murine helper T cell clone II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 138. 3688.
22. Grun, J. L., and P. H. Maurer 1989. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles the role of endogenous interleukin 1 in proliferative responses. Cell. Immunol 121:134.
23. Yang, X., and K T Hayglass. 1993. Allergen-dependent induction of interleukin-4 synthesis in vivo Immunology 78:74.
24. Powers, G. D , A. K. Abbas, and R. A. Miller 1988. Frequencies of IL-2 and IL-4-secreting T cells in naive and antigen-stimulated lymphocyte populations. J Immunol. 140:3352.
25. Swam, S L., D T. McKenzie, A. D. Weinberg, and W. Hancock 1988 Characterization of T helper 1 and 2 subsets in normal mice: helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol 141.3445.
26. Mohler, K M , and L D Butler. 1990 Differential production of IL-2 and IL-1 mRNA in vivo after primary sensitization. J. Immunol. 145:1734.
27. McCormack, J. E., J. E. Callahan, J. Kappler, and P. Marrack. 1993. Profound deletion of mature T cells in vivo by chrome exposure to exogenous superantigen. J. Immunol 150:3785.
28. Kearney, E. R., K. A Pape, D. Y. Loh, and M. K Jenkins. 1994 Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
29. Thompson, C B , T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C H. June 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 86:1333
30. + cytotoxic T lymphocytes in the absence of exogenous help J. Exp Med. 177:1791.
31. Nickoloff, B. J., R. S Mitra, K. P. Lee, L. A. Turka, J. Green, C. B Thompson, and Y. Shimizu. 1993. Discordant expression of CD28 ligands, BB-1 and B7, on keratinocytes in vitro and psoriatic cells in vivo. Am. J. Pathol. 142:1029
32. Boussiotis, V. A., G. J Freeman, J. Daley, G. Gray, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. Natl. Acad. Sci. USA 90:11059.
33. Walunas, T L , D.J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation Immunity 1:405.
34. Vella, A. T., J. E. McCormack, P. S. Linsley, J. W. Kappler, and P Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261
35. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol 155:1032
36. Boussiotis, V. A , G. J. Freeman, J. D Griffin, G. S. Gray, J. G. Gribben, and L M Nadler 1994. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1665.
37. Gribben, J G., G. J. Freeman, V. A. Boussiotis, P. Rennert, C. L. Jellis, E. Greenfield, M. Barber, J. Restivo, V. A , X. Ke, G. S. Gray, and L. M. Nadler. 1995. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92:811.